Microbot Medical shares are trading higher after the company announced Lahey Hospital & Medical Center agreed to become one of the U.S. sites for the first-ever human trial of the LIBERTY Robotic Surgical System.
Portfolio Pulse from Benzinga Newsdesk
Microbot Medical announced that Lahey Hospital & Medical Center will be one of the U.S. sites for the first-ever human trial of the LIBERTY Robotic Surgical System, leading to higher trading of MBOT shares.
May 25, 2023 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Microbot Medical shares are trading higher after the announcement of Lahey Hospital & Medical Center hosting the first-ever human trial of the LIBERTY Robotic Surgical System.
The news of Lahey Hospital & Medical Center hosting the first-ever human trial of the LIBERTY Robotic Surgical System is a significant milestone for Microbot Medical. This partnership and trial can potentially lead to increased adoption of the system, boosting the company's revenue and stock price. As a result, MBOT shares are trading higher, and the short-term impact is positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100